Investigative Ophthalmology & Visual Science Cover Image for Volume 64, Issue 8
June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Novel extracellular matrix based hydrogel for lacrimal gland tissue engineering
Author Affiliations & Notes
  • Katharina Elisabeth Wiebe-Ben Zakour
    Ophthalmology, Universitatsklinikum Dusseldorf, Duesseldorf, Nordrhein-Westfalen, Germany
  • Sema Kaya
    Ophthalmology, Universitatsklinikum Dusseldorf, Duesseldorf, Nordrhein-Westfalen, Germany
  • Amina Cheikh-Rouhou
    Ophthalmology, Universitatsklinikum Dusseldorf, Duesseldorf, Nordrhein-Westfalen, Germany
  • Michael Hacker
    Heinrich-Heine-Universitat Dusseldorf, Dusseldorf, Nordrhein-Westfalen, Germany
  • Gerd Geerling
    Ophthalmology, Universitatsklinikum Dusseldorf, Duesseldorf, Nordrhein-Westfalen, Germany
  • Joana Witt
    Ophthalmology, Universitatsklinikum Dusseldorf, Duesseldorf, Nordrhein-Westfalen, Germany
  • Footnotes
    Commercial Relationships   Katharina Wiebe-Ben Zakour None; Sema Kaya None; Amina Cheikh-Rouhou None; Michael Hacker None; Gerd Geerling None; Joana Witt None
  • Footnotes
    Support  none
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 177. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Katharina Elisabeth Wiebe-Ben Zakour, Sema Kaya, Amina Cheikh-Rouhou, Michael Hacker, Gerd Geerling, Joana Witt; Novel extracellular matrix based hydrogel for lacrimal gland tissue engineering. Invest. Ophthalmol. Vis. Sci. 2023;64(8):177.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The pathological mechanisms leading to aqueous deficient dry eye disease (ADDE) are still not fully understood, so current treatment is mostly palliative and lacks regenerative or reconstructive strategies. Tissue specific hydrogels (HG) derived from decellularized extracellular matrix have emerged as a promising substrate in tissue engineering due to their cell function promoting properties, therefore representing the ideal basis for an in vitro model to investigate ADDE pathology and treatment. Our aim was to produce a decellularized (d) lacrimal gland (LG) HG that ensures physiological cultivation of LG cells and meets the basic requirements for bioprinting a LG in vitro model.

Methods : Porcine LG were decellularized and hydrolyzed with pepsin for 4, 12, 24, 48, or 96 h to obtain dLG-HG. dLG-HG samples (n=6) were analyzed rheologically (gelation kinetics and stiffness) and biochemically (collagen, glycosaminoglycan, and hyaluronan content). Proliferation of porcine LG epithelial cells (EC) grown on dLG-HG, Matrigel and collagen-I-HG was analyzed by MTT assay. EC mediated degradation of the different HG substrates was quantified by remaining HG area. Finally, the secretion capacity of EC was investigated by β-hexosaminidase assay.

Results : Gelable dLG-HG with similar gelation kinetics and stiffness (all p≥0.798) were generated at all hydrolysis times. Hydrolysis time had no effect on collagen and glycosaminoglycan content (all p>0.856 and 0.970, respectively), while hyaluronan content increased in a time dependent manner (all p<0.001). EC proliferation on dLG-HG hydrolyzed for ≥24 h was higher than on Matrigel by 63.14±26.27% (p=0.04), 67.37±27.75% (p=0.039) and 77.97±38.35% (p=0.002), respectively. After 14 days of cultivation with EC, dLG-HG degraded to 6.99±2.55% (4 h) to 3.39±1.25% (96 h) of the original area (all p<0.0001). The secretion capacity of EC cultured on dLG-HG hydrolyzed for ≥24 h was increased by 50-76% (p≤0.006) compared to collagen-I and by 37-61% (p≤0.033) compared to Matrigel.

Conclusions : dLG-HG hydrolyzed for ≥24 h positively affected proliferation and function of EC compared to collagen-I and Matrigel, thus representing a suitable substrate for a LG in vitro model. Due to its rheological and biochemical properties, dLG-HG meets the basic requirements of a bioink. However, the cell mediated degradation should be slowed down to enable longer cultivation.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×